Afecta Pharmaceuticals is an early clinical stage small molecule therapeutics company focused on developing precision medicines to treat chronic disorders and cancers more effectively. Afecta has a validated, proprietary Artificial Intelligence disease/drug targeting platform, PharmetRx®, to discover and optimize Multi-Target drug compounds and formulate them in NanoRx®, our tissue-specific drug delivery technology. Backed by an experienced management team, Afecta is currently advancing AFX-220, our clinically proven lead candidate that effectively treats the disruptive behaviors that occur in children and adolescents with several neurodevelopmental disorders such as Autism, AD/HD, and others. Please visit our website to learn more, register to access our Executive Summary, and receive our latest updates.

Afecta Pharmaceuticals

This department focuses on advancing bioinformatics solutions while driving business development initiatives to foster growth.

Afecta Pharmaceuticals

Org chart

Teams

Bioinformatics and Business Development

Offices

Afecta Pharmaceuticals

Org chart

Teams

Bioinformatics and Business Development

Offices

Related companies